Article

Prevalence of Mutations in Common Tumour Types in Northern England and Comparable Utility of National and International Trial Finders

2023-06-28

Abstract excerpt

PURPOSE: Tumour genomic profiling is of increasing importance in early phase trials to match patients to targeted therapeutics. Mutations vary by demographic group, however, regional differences are not characterised. This was investigated by comparing mutation prevalence for common cancers presenting to Newcastle Experimental Cancer Medicine Centre (ECMC) to The Cancer Genome Atlas (TCGA) and utility of trial ma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2fa0f4a2-2738-512f-8c10-35a1baf2bee9
DOI: 10.21203/rs.3.rs-3100087/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prevalence of Mutations in Common Tumour Types in Northern England and Comparable Utility of National and International Trial FindersDOI 10.21203/rs.3.rs-3100087/v1Read

Prevalence of mutations in common tumour types in Northern England and comparable utility of national and international Trial Finders.Semantic proximity Read

Overview of Molecular Diagnostics in Irish Clinical OncologySemantic proximity Read

Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.Semantic proximity Read

Implementation of circulating tumour DNA multi-target mutation testing in plasma: a perspective from an external quality assessment providers' survey.Semantic proximity Read

Frequency of next-generation sequencing, prevalence of targetable mutations and response to targeted therapies amongst patients with metastatic urothelial cancer in Ireland: a multi-centre retrospective study of real-world data.Semantic proximity Read

Computational optimisation of targeted DNA sequencing for cancer detection.Semantic proximity Read

The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies.Semantic proximity Read

Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.Semantic proximity Read

The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review.Semantic proximity Read

Do more targets allow more cancer treatments, or not?Semantic proximity Read

Germline mismatch repair (MMR) gene analyses from English NHS regional molecular genomics laboratories 1996–2020: development of a national resource of patient-level genomics laboratory recordsSemantic proximity Read